TenSixteen Bio garners $40m
TenSixteen Bio, which is focused on treating age-related diseases at earlier stages, has raised $40 million in funding.
TenSixteen Bio, which is focused on treating age-related diseases at earlier stages, has raised $40 million in funding.
Copyright PEI Media
Not for publication, email or dissemination